Explore 3 Stock Ideas & Industry Insights Download Free Report

Cannabis Bioscience International Holdings Inc.

Company price
0.0002 USD 0.00 ( 100.00%)
Last update at 2026-11-20T16:03:00Z
VOLUME
440000
Market Cap
4.65M

Momentum Score

…

Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products. The company was founded in 2003 and is headquartered in Houston, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cannabis Bioscience International Holdings Inc. (CBIH) is an OTC Pink–listed microcap that, based on public disclosures, operates in the cannabis/hemp sector with a stated focus on developing and commercializing cannabinoid-based products and related technologies. Major long-term growth drivers may include expansion of legal cannabis and hemp markets, product development, and potential regulatory changes that could support broader market access, and the company may appeal to investors seeking early-stage exposure if execution and funding materialize.
Key risks include limited public disclosure and low liquidity typical of OTC Pink microcaps, execution and financing risk that could constrain operations, and substantial regulatory and market uncertainty inherent to the cannabis industry.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.12M
Revenue Per Share
-
Gross Profit TTM
0.10M
Debt / Equity
-0.36
ROE
-
Net Debt
0.41M
ROCE
40.30%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Income before tax -0.55M -0.65M -1.07M -0.89M -0.16M
Net income -0.55M -0.65M -1.03M -0.89M -0.16M
Selling general administrative 0.42M 0.65M 1.15M - -
Selling and marketing expenses - - 0.05M - -
Gross profit 0.26M 0.20M 0.22M 0.17M 0.76M
Reconciled depreciation 0.03M -0.01M 0.04M - -
Ebit -0.37M -0.49M -0.94M - -0.11M
Ebitda -0.34M -0.50M -0.91M -0.83M -0.11M
Depreciation and amortization 0.03M -0.01M 0.04M - 0.00M
Operating income -0.42M -0.49M -0.98M -0.89M -0.11M
Other operating expenses 0.72M 0.73M 1.30M 1.10M 0.88M
Interest expense 0.18M 0.17M 0.09M 0.05M 0.04M
Net interest income -0.18M -0.17M -0.09M - -
Income tax expense - 0.00M -0.04M - -0.00M
Total revenue 0.30M 0.25M 0.32M 0.21M 0.76M
Total operating expenses 0.68M 0.69M 1.21M 1.06M 0.87M
Cost of revenue 0.04M 0.05M 0.09M 0.05M 0.00M
Total other income expense net -0.13M -0.17M -0.09M 0.00M -0.04M
Net income from continuing ops -0.55M -0.65M -1.03M - -
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Total assets 0.03M 0.06M 0.04M 0.11M 0.15M
Other current assets 0.00M 0.00M 0.00M - -
Total liab 1.20M 1.14M 0.64M 0.47M 0.45M
Total stockholder equity -1.16M -1.08M -0.59M -0.36M -0.30M
Other current liab 0.67M 0.50M 0.21M 0.02M 0.01M
Capital stock 0.00M 0.00M 0.00M - -
Retained earnings -5.88M -5.33M -4.68M -3.65M -2.76M
Other assets - - 0.00M - -
Cash 0.01M 0.00M 0.01M 0.03M 0.04M
Total current liabilities 0.95M 0.88M 0.39M 0.22M 0.19M
Current deferred revenue - - 0.03M - -
Net debt 0.41M 0.44M 0.38M 0.35M 0.38M
Short term debt 0.17M 0.18M 0.14M 0.14M 0.16M
Short long term debt 0.17M 0.16M 0.14M - -
Short long term debt total 0.42M 0.44M 0.39M 0.39M 0.42M
Other stockholder equity 4.72M 4.26M 4.09M 3.29M 2.46M
Total current assets 0.03M 0.02M 0.02M 0.05M 0.05M
Net receivables 0.02M 0.02M 0.01M 0.02M 0.01M
Long term debt 0.25M 0.25M 0.25M - -
Inventory - - -0.00M - -
Accounts payable 0.10M 0.20M 0.11M 0.07M 0.02M
Non currrent assets other - - -0.00M - -
Non current assets total 0.00M 0.04M 0.02M 0.06M 0.09M
Capital lease obligations 0.00M 0.03M 0.00M - -
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Net borrowings 0.10M 0.40M 0.07M - -
Total cash from financing activities 0.34M 0.47M 0.89M 0.85M 0.42M
Net income -0.55M -0.65M -1.03M -0.89M -0.16M
Change in cash 0.01M -0.01M -0.02M -0.01M -0.09M
Begin period cash flow 0.00M 0.01M 0.03M 0.04M 0.13M
End period cash flow 0.01M 0.00M 0.01M 0.03M 0.04M
Total cash from operating activities -0.33M -0.48M -0.91M -0.86M -0.51M
Issuance of capital stock 0.24M 0.07M 0.80M - -
Depreciation 0.03M -0.01M 0.04M - 0.00M
Change to account receivables 0.00M -0.01M -0.00M -0.00M -0.01M
Sale purchase of stock - - - - -0.00M
Other cashflows from financing activities 0.34M - - - -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.06M 0.05M 0.16M 0.02M -0.35M
Stock based compensation - 0.00M 0.01M - -
Other non cash items 0.25M 0.14M -0.08M -0.03M 0.09M
Free cash flow -0.33M -0.48M -0.91M -0.86M -0.51M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CBIH
Cannabis Bioscience International Holdings Inc.
0.00
100.00%
0.00 - - 37.62 0.01 40.90 0.02
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

Cannabis Bioscience International Holdings Inc.

Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products. The company was founded in 2003 and is headquartered in Houston, Texas.

6201 Bonhomme Road, Houston, TX, United States, 77036

214 733 0868

2

Name Title Year Born
Mr. Dante Picazo CEO, Chief Accounting Officer & Director 1956
Mr. John Jones Treasurer & Director 1965
Dr. Jose A. Torres Torres National Medical Director, Secretary & Director 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…